Inhibition of angiogenesis decreases alveolarization in the developing rat lung.

By M. Jakkula, T. L. Le Cras, S. Gebb, K. Hirth, R. Tuder, N. Voelkel, S. Abman. American Journal of Physiology - Lung cellular and Molecular Physiology, 2000

639 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/1afeeef2b2105092ce72b6c89bc3afd8d53777cd

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Y. Kasahara
2. R. Tuder
3. A. Jobe
4. E. Bancalari
5. S. Abman
6. L. Taraseviciene‐Stewart
7. N. Voelkel
8. T. L. Cras

Citations in the corpus

• Bronchopulmonary dysplasia. (2001, background): “Abman reported that the administration of antiangiogenesis drugs such as fumagillin and thalidomide impaired pulmonary vascular and alveolar development in rats, demonstrating that angiogenesis can be a regulator of alveolar septation (53).”
• Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. (2000, background): “The quantitation of the peripheral pulmonary arteries filled with barium was performed as described recently (17).”